Track the 켈스 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 켈스 has recorded 11 public disclosures. The latest transaction was disclosed on 8 August 2025 (Purchase). Among the most active insiders: 한국투자파트너스. Every trade is accessible without an account.
11
Insider Decl.
n/a
Thresholds
n/a
10 ops.
Buy Volume
n/a
n/a
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.